8月21日，康乃德生物(CNTB)盘中上涨6.59%，截至22:20，报1.78美元/股，成交4.44万美元，总市值9918.45万美元。
财务数据显示，截至2025年06月30日，康乃德生物收入总额4.8万美元，同比减少99.8%；归母净利润-2317.1万美元，同比减少476.52%。
大事提醒：
8月13日，康乃德生物2025财年中报归属股东应占溢利-2317万美元，同比下降476.52%，基本每股收益-0.42美元。
资料显示，康乃德生物医药控股有限公司是一家拥有临床阶段产品、全球化布局的生物医药公司,通过自主研发的T细胞功能调节平台开发创新疗法,从而改善炎症性免疫疾病患者的生活品质。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.